Newsletters - July 1997

  1. You are here:  
  2. Home
  3. Newsletters - July 1997

Boswellia Serrata : Use in Ulcerative Colitis

Boswellic acids, the biologically active ingredients of Boswellia serrata gum resin, are used to treat inflammatory disorders.

A recent report published in the European Journal of Medical Research (Jan 20, 1997) showed that treatment with Boswellia serrata gum resin induced remission of symptoms in 82% of the ulcerative colitis patients studied. This treatment compared favorably with conventional treatment using NSAIDS.

Boswellin® supplied by Sabinsa Corporation is standardized for 70% boswellic acids.

    VISIT US

  • Sabinsa Canada Inc.
    6800 Kitimat Road, Unit 28,
    Mississauga, ON L5N 5M1
    Canada

  • +1 905-286-6616
  • +1 437-988-1663
  • info@sabinsa.ca

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos
Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.